Badenhorst T, Svirskis D, Merrilees M, Bolke L, Wu Z
Phase 3 trials are ongoing, and without completed large-scale safety and efficacy data, the compound cannot be considered ready for routine clinical use
We still require controlled human trials, standardized dosing, and long-term safety studies
Biomass-derived, hierarchical porous carbon possesses excellent properties with abundant oxygen-containing functional groups and defect centers to anchor and disperse Pt NPs, thereby improving the HER catalytic performance
This is one of the most common things patients tell us that they felt something shift faster than they expected after years of trying other approaches